The IASLC lung cancer staging project: Proposals for the revision of the M descriptors in the forthcoming eighth edition of the TNM classification of lung cancer

Journal of Thoracic Oncology

Volumn 10, Issue 11, 2015, Pages 1515-1522

  Eberhardt, Wilfried E E ^a   Mitchell, Alan ^b   Crowley, John ^b   Kondo, Haruhiko ^c   Kim, Young Tae ^d   Turrisi, Andrew ^e   Goldstraw, Peter ^f   Rami Porta, Ramon ^g,h  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b Fred Hutchinson Cancer Research Center   (United States)

^c KYORIN UNIVERSITY   (Japan)

^d Seoul National University Hospital   (South Korea)

^e SINAI GRACE HOSPITAL   (United States)

^f ROYAL BROMPTON HOSPITAL   (United Kingdom)

^g HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^h INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Lung cancer; Metastases; Staging

Indexed keywords

ADRENAL METASTASIS; BILATERAL CANCER; CANCER PROGNOSIS; CANCER RESEARCH; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DATA BASE; HUMAN; LUNG CANCER; LUNG METASTASIS; MAJOR CLINICAL STUDY; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PERICARDIAL EFFUSION; PRIORITY JOURNAL; REVIEW; THORAX TUMOR; CLASSIFICATION; FEMALE; LUNG TUMOR; MALE; PATHOLOGY;

CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING;

EID: 84945255444     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000673     Document Type: Review

References (30)

1. Goldstraw P, Crowley J, Chansky K, International Association for the Study of Lung Cancer International Staging Committee; Participating Institutions The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007 2 706 714
2. Rami-Porta R, Bolejack V, Giroux DJ, International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Board Members and Participating Institutions The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer. J Thorac Oncol 2014 9 1618 1624
3. De Wever W, Vankan Y, Stroobants S, Verschakelen J, Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer. Eur Respir J 2007 29 995 1002
4. De Leyn P, Dooms C, Kuzdzal J, Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg 2014 45 787 798
5. Falcoz PE, Puyraveau M, Thomas PA, ESTS Database Committee and ESTS Minimally Invasive Interest Group Video-Assisted thoracoscopic surgery versus open lobectomy for primary non-small-cell lung cancer: a propensity-matched analysis of outcome from the European Society of Thoracic Surgeon database. Eur J Cardiothorac Surg 2015 Apr 26. [Epub ahead of print]
6. Shaw MG, Ball DL, Treatment of brain metastases in lung cancer: strategies to avoid/reduce late complications of whole brain radiation therapy. Curr Treat Options Oncol 2013 14 553 567
7. Kavanagh BD, McGarry RC, Timmerman RD, Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases. Semin Radiat Oncol 2006 16 77 84
8. Mok TS, Wu YL, Thongprasert S, Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med 2009 361 947 957
9. Paz-Ares LG, de Marinis F, Dediu M, PARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer. J Clin Oncol 2013 31 2895 2902
10. Vansteenkiste J, Crinò L, Dooms C, Panel Members; Panel Members 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up. Ann Oncol 2014 25 1462 1474
11. Eberhardt WE, De Ruysscher D, Weder W, 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer. Ann Oncol 2015 26 1573 1588
12. Besse B, Adjei A, Baas P, Panel Members 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease. Ann Oncol 2014 25 1475 1484
13. Geiger GA, Kim MB, Xanthopoulos EP, Stage migration in planning PET/CT scans in patients due to receive radiotherapy for non-small-cell lung cancer. Clin Lung Cancer 2014 15 79 85
14. Postmus PE, Brambilla E, Chansky K, International Association for the Study of Lung Cancer International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer. J Thorac Oncol 2007 2 686 693
15. Rami-Porta R, Bolejack V, Crowley J, IASLC Staging and Prognostic Factors Committee, Advisory Boards and Participating Institutions The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer. J Thorac Oncol 2015 10 990 1003
16. Asamura H, Chansky K, Crowley J, The lASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol 2015 10 990 1003
17. Kaplan EL, Meier P, Nonparametric estimation from incomplete observations. J Am Stat Assoc 1953 53 457 481
18. Cox DR, Regression models and life tables (with discussion). J R Stat Soc 1972 B34 187 220
19. SAS User Guide. SAS version 9.2 2009 California: SAS Institute
20. Ryu JS, Ryu HJ, Lee SN, Prognostic impact of minimal pleural effusion in non-small-cell lung cancer. J Clin Oncol 2014 32 960 967
21. Toufektzian L, Sepsas E, Drossos V, Gkiozos I, Syrigos K, Pleural lavage cytology: where do we stand? Lung Cancer 2014 83 14 22
22. Salama JK, Schild SE, Radiation therapy for oligometastatic non-small cell lung cancer. Cancer Metastasis Rev 2015 34 183 193
23. Griffioen GH, Toguri D, Dahele M, Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors. Lung Cancer 2013 82 95 102
24. Gray PJ, Mak RH, Yeap BY, Aggressive therapy for patients with non-small cell lung carcinoma and synchronous brain-only oligometastatic disease is associated with long-Term survival. Lung Cancer 2014 85 239 244
25. Tönnies M, Pfannschmidt J, Bauer TT, Metastasectomy for synchronous solitary non-small cell lung cancer metastases. Ann Thorac Surg 2014 98 249 258
26. Congedo MT, Cesario A, Lococo F, Surgery for oligometastatic non-small cell lung cancer: long-Term results from a single center experience. J Thorac Cardiovasc Surg 2012 144 444 452
27. Bonnette P, Puyo P, Gabriel C, Groupe Thorax Surgical management of non-small cell lung cancer with synchronous brain metastases. Chest 2001 119 1469 1475
28. Tanvetyanon T, Robinson LA, Schell MJ, Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis. J Clin Oncol 2008 26 1142 1147
29. De Ruysscher D, Wanders R, van Baardwijk A, Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-Term results of a prospective phase II trial (Nct01282450). J Thorac Oncol 2012 7 1547 1555
30. He YY, Zhang XC, Yang JJ, Prognostic significance of genotype and number of metastatic sites in advanced non-small-cell lung cancer. Clin Lung Cancer 2014 15 441 447